10 research outputs found
Chinese literary works translated into Baba Malay: a bibliographical study
No full textAnalyses 68 unique titles of Baba translated works published between 1889 and 1950. The titles are held in the libraries of the University of Malaya (UM), Science University Malaysia (USM), National University of Malaysia (UKM), the Dewan Bahasa dan Pustaka (DBP), National University of Singapore (NUS), National Library of Singapore (NLS) and the British Library (BL). The results reveal three periods of active publication of Baba translated works. A total of 18 works were translated before World War I, followed by 10 just after the war, 39 titles were published before the break of the World War II and 1 was identified in 1950. There were 103 persons involved in the 68 translated works, some of whom are responsible for more than one title. The most prominent translators were Chan Kim Boon, Wan Boon Seng, Seow Chin San and Lee Seng Poh. Some of the translators were also be editors, illustrators or editors. There were 31 publishers and 21 printing presses involved, all were located in Singapore. The most active publishers were Wan Boon Seng, Kim Seck Chy Press and Nanyang Romanised Malay Book Co. The translated works mainly cover historical classical Chinese stories, chivalrous stories, romances, folklore and legends. The titles were priced between 10 cents to 2 dollars in Straits currency. The University of Malaya Library held the largest number of unique title (62) out of which 15 were unique titles
Dynamic matrix controller design and optimization based on a MIMO double-effect pilot plant model
No full textDynamic Matrix Control (DMC) has developed considerably over the last two decades, both within the research control community and in the industry. The reason for this success can be attributed to the fact that it is, perhaps, the most general way of posing the process control problem in the time domain. DMC formulation integrates optimal control, control of process with dead time, multivariable control and future references when available. Another advantage of DMC is that because of the finite control horizon used, constraints and in general non-linear processes which are frequently found in the industry, can be handled.Master of Science (Computer Control and Automation
Trade balance and marcoeconomic variables integration: an empirical evidence on Asean 5 from 1984 to 2010
No full textAngiopoietin-like 4 Mediates Colonic Inflammation by Regulating Chemokine Transcript Stability via Tristetraprolin
No full textAbstractMany gastrointestinal diseases exhibit a protracted and aggravated inflammatory response that can lead to hypercytokinaemia, culminating in extensive tissue damage. Recently, angiopoietin-like 4 (ANGPTL4) has been implicated in many inflammation-associated diseases. However, how ANGPTL4 regulates colonic inflammation remains unclear. Herein, we show that ANGPTL4 deficiency in mice (ANGPTL4−/−) exacerbated colonic inflammation induced by dextran sulfate sodium (DSS) or stearic acid. Microbiota was similar between the two genotypes prior DSS challenge. A microarray gene expression profile of the colon from DSS-treated ANGPTL4−/− mice was enriched for genes involved in leukocyte migration and infiltration, and showed a close association to inflamed ulcerative colitis (UC), whereas the profile from ANGPTL4+/+ littermates resembled that of non-inflamed UC biopsies. Bone marrow transplantation demonstrates the intrinsic role of colonic ANGPTL4 in regulating leukocyte infiltration during DSS-induced inflammation. Using immortalized human colon epithelial cells, we revealed that the ANGPTL4-mediated upregulation of tristetraprolin expression operates through CREB and NF-κB transcription factors, which in turn, regulates the stability of chemokines. Together, our findings suggest that ANGPTL4 protects against acute colonic inflammation and that its absence exacerbates the severity of inflammation. Our findings emphasize the importance of ANGPTL4 as a novel target for therapy in regulating and attenuating inflammation.</jats:p
Asymptomatic COVID‐19: disease tolerance with efficient anti‐viral immunity against SARS‐CoV‐2
No full textAbstract The immune responses and mechanisms limiting symptom progression in asymptomatic cases of SARS‐CoV‐2 infection remain unclear. We comprehensively characterized transcriptomic profiles, cytokine responses, neutralization capacity of antibodies, and cellular immune phenotypes of asymptomatic patients with acute SARS‐CoV‐2 infection to identify potential protective mechanisms. Compared to symptomatic patients, asymptomatic patients had higher counts of mature neutrophils and lower proportion of CD169+ expressing monocytes in the peripheral blood. Systemic levels of pro‐inflammatory cytokines were also lower in asymptomatic patients, accompanied by milder pro‐inflammatory gene signatures. Mechanistically, a more robust systemic Th2 cell signature with a higher level of virus‐specific Th17 cells and a weaker yet sufficient neutralizing antibody profile against SARS‐CoV‐2 was observed in asymptomatic patients. In addition, asymptomatic COVID‐19 patients had higher systemic levels of growth factors that are associated with cellular repair. Together, the data suggest that asymptomatic patients mount less pro‐inflammatory and more protective immune responses against SARS‐CoV‐2 indicative of disease tolerance. Insights from this study highlight key immune pathways that could serve as therapeutic targets to prevent disease progression in COVID‐19
DataSheet_1_Data-Driven Analysis of COVID-19 Reveals Persistent Immune Abnormalities in Convalescent Severe Individuals.docx
No full textSevere SARS-CoV-2 infection can trigger uncontrolled innate and adaptive immune responses, which are commonly associated with lymphopenia and increased neutrophil counts. However, whether the immune abnormalities observed in mild to severely infected patients persist into convalescence remains unclear. Herein, comparisons were drawn between the immune responses of COVID-19 infected and convalescent adults. Strikingly, survivors of severe COVID-19 had decreased proportions of NKT and Vδ2 T cells, and increased proportions of low-density neutrophils, IgA+/CD86+/CD123+ non-classical monocytes and hyperactivated HLADR+CD38+ CD8+ T cells, and elevated levels of pro-inflammatory cytokines such as hepatocyte growth factor and vascular endothelial growth factor A, long after virus clearance. Our study suggests potential immune correlates of “long COVID-19”, and defines key cells and cytokines that delineate true and quasi-convalescent states.</p
Data-Driven Analysis of COVID-19 Reveals Persistent Immune Abnormalities in Convalescent Severe Individuals
No full textSevere SARS-CoV-2 infection can trigger uncontrolled innate and adaptive immune responses, which are commonly associated with lymphopenia and increased neutrophil counts. However, whether the immune abnormalities observed in mild to severely infected patients persist into convalescence remains unclear. Herein, comparisons were drawn between the immune responses of COVID-19 infected and convalescent adults. Strikingly, survivors of severe COVID-19 had decreased proportions of NKT and Vδ2 T cells, and increased proportions of low-density neutrophils, IgA+/CD86+/CD123+ non-classical monocytes and hyperactivated HLADR+CD38+ CD8+ T cells, and elevated levels of pro-inflammatory cytokines such as hepatocyte growth factor and vascular endothelial growth factor A, long after virus clearance. Our study suggests potential immune correlates of “long COVID-19”, and defines key cells and cytokines that delineate true and quasi-convalescent states
Minbar al-Sharq, No.340 (vol. 23, Jan, 26, 1945)
No full textArabic-language newspaper founded in Geneva in 1922, where it was published in French under the title La Tribune d\u27Orient. Moved to Cairo in 1937, where it was published weekly under the current title.ee ee ee Rennsatetieien el ah tele OU SL ge Gb yésat de > sdaw 8 Je Ley Ways G gee -,»e ve ux gitll Kl ce Nod 5 ol bs ho ¢ aeNI iS} s etal (5 runall sel 5 SRE putle ; aw 9 oo &\u27 bexs\-» ee ale; eens Wels Gat ol gota c* § glad! ouke a a baw I} wl) cola, PS fag jathn Oo 2 bjahs oS Ose “*\ e) ISN, aoe on Ol : aul J lal Mic oe ew a “elo Es 35 P ales. | legs od 44> Om paul od cy se ag GJ elle TS Sy sl el Oger 5, “ys ot Lede odudl oS ¢ J gS aA | pas ge ol a: 2 Ant alts at Sl + Aye lad! ec! ls epalie uw de ee yn ae Sola ll co : : Oe 2 IAA par: om pall ao ss Bele or gel Cae 131 NI Lo =e Rt! J OF Fal on Rs : ele pee + etl 6 3 | ts les\u279 yous yg glen, ee Gall ela . eo bans yh fast 5 ro Ka Jil S , Care ya| yee pw see ca ro Og?pcou oye! cull Jb G> ¢ oil af Jind x 3 9gt! oT ode dled lel 6 dak Us 6 pez, a, jel Ohl + css ok I ce — gw y! law, oak A RA OY Lb loll s ME a .. Ue © al . duo y 12 | cldl Isls Dyan hac tle te cfs ap ae as pais me oa & Ws plat Cost ane es dues Sluis Po Aor loot dye ee cnsb of cn he > ey ee cls SIS! J aoe gis Ol : J ot © > eglail oY ails 8 yr 2h yrbed aie Vols lp cas gh s a ladles’ Louse Vlas 6: calves ols eiaplihel 60 go wll leroy gar endo E nil Ne Jia Ss. oui abs a aca! BS 9 Sale ene | Jl beds Od! 3S lat elit . oe Jal vl Canad) b 3 \; ge fans 9 dale sed) ching Gog oss. a » Ay Jd| Ol | 4! ol gil bo 9 cl 9 . Sena YW ob oH al w les tle Us . pam al el sae 3 ON, te ME : a 9 yb oll Jasll sc dee gill LLadl BO yladly © O91 ET tle dtd grmai Ole Gill 4 1a.) aii oe be asl) a’(2 pl Garey” % a abl) (Ke ce Od dy dole dein, Y agneall & yells SL oy ie Aas yall yas pn veal ae lGht 6 % 01% oe bd! See lena» Jall dle Ol ree ai gs leary “ll G-gi-g gaoDdl cpleaall solE NI ; Nac 3 gcuall (yy laall de came J Maze SI C22 ote 35 Ol Casall SS Caceal ails. V7 sells 1G j | Wye 8 idols ley (BeN | Ais age re EREDAR eminence ome ut Aas Loess ‘I BANG Ne atl Reg ER yKew IO. pan “ call | - w pels 44 Aaa 3 a gill 3h “id ta Mo) ea 3 Sg MNS 0.56 gl baths ¢ J gill Saal! ga bates cb Doll oaladl, « ell Ogle Vol Cwloedl 3 dad cp lows) cas fs ce pole Sl lls Sneed col»: ig EMI us oo ‘ os Lal Gil, cmbodl oe od Oy leadls oles NI, y BILAN, .. oth Ui ig yaa as’ | Vssoy ere éNs J sass 0 pig of Sal je J 5hl da, thls 605 Sambal ohal yall bail gS Aang Crem ye WB als bool gh bey cic >| da ads” | cs danke | pal pits: 5 pam My nal ef old | « plan! Shim SI cag « cle | «da glell ano ut sa: ao! O33 caress decile 351 of Ol pd cats ¢ lel Crane de dz | o Ash adh a3 lall_y Arena ane Ol Slats Arena -@ Gre Wot ahd coy Sk dy3 ob gl ols can * lie di, salgcl all pao Je la ¢ Kaley ab oe Joy beled!gl bl ently gga D oy el 4.) \oesi NI S t is I ya Asdeome O! ylselle in 2b sti, FAI Ov gel Co Sl, ut GOSS Ola « toh} «Wye grad dmb Salbl oS oe dt Lo yall de ne 3 JL chy sally pal solacdl silall sel ys cls of Sslel gil ley pills DIEM ya adi |e oles oS esis 6 (Sse | PIS Settad 6959 Sue OF wtogrs daly 6 Sd)OlAad ds Bh wl PN co I Ctanbst| og Pus: aad! exptlls x a - ll pan Oa §4 Se | 5th gal de Gall + oS) ded Pda MM Aantl dcLL I = paddy peYI ble i il wea) ~ Oall, daar dm J) Jen}a — szt al Daly! a ¢- pent Lamces NI Fe ASV hi ue 6 sls oy Ol cyt baal o a Aili lel & pall LL Cus lan Coes \ple ow ES! 3 ge cee ol ak | gat lls . 2 ytill wl \es 6 Added LEY! atl o tbl a head! darbaw9 ag lia BZ Ps ONL ot Ogle cm hs elit! ty? oa 6 or yall pee Sitiod Old elye ya O phases pep pelea ce Bs Seleasi a moe Sells 3 sell Goal Joti Ola 6 te gale Rann ning m toil otue ck i. eS + 0> Lenk Sovak (hay yall Sum I de Mazel ay all J gull denle ceopeai Ob geri Lilly . ode om pal ad gee e\—all S rua in at 59 2)oy Make Isis ya SST, Ol hd arbsy aa Akal oe ets 6 lj te oul “OUVEY Dogeki le Sts | [tlsl ol gm colae Ge Aigtiyee | Ja) ¢ - A Jelp: sat MRS wie deen dls 6 \es SI a J gles ‘VI 6 V pleas| eon. 3 6 er gstens of wen il jal oye L>| Ano » Ja naw lead! a lSIl oe jaw JL tle ol ots pa lal Is pled ost oe al da Oho dls az} yl Sal dt Geet Vary ols ee eupeegiun Sera c om GUL dys Genet Ol 2S 6 ple olaczall fle s Bdeoely Sb) ot a gh! Slais 6 G girall SB) andere) OI lee \o| (33 jal fps Ae 2a Ol azoalaa 7 phe of Devs Joly LE clas «dele Crs a> alls 3 Rie | a . ed pr iE eee eat : Sle Ly Aerts Fe Col gal co gall all all eo” ye of Nai ay Crs sm all VS las Oh bund(| us Sal gblels 485 e oy a sires Sloe 5: 54 J we 8? es alvin, | Sia me cows fa - Gy»! Ags i PAry Shecei.s me aes ce as eUS 3,253 31 ¥9 Na Sy Side AN 3 CF gwea (Ke Osis orkll = a ee SS \e 3a oi us ells a gb e sla} al re gl 2 a lke 5 6 aj; - Sty y Sas ae al 5) ols w+! Dg 38 lah cy loedl way anew 2 epcti:d =" : a sul asl a Je ds opal Mt. mA JF Sl ea 3 aster nib oo re a A> |:lest | sae ur vel Ry ee as » r uf : wy sail > gaak tla cb Js 4a“Ll eres er » ea I ¢ ple “lpia “aS Sashe 3 BS aes Bee ; Z 3 ral Lak sa OFAN o ea He ¢ aah te ee al ob “ Ne S re ‘ = n plate + ‘ es ; ‘ 2 se : » - Vale Cytaw Jses Jd oy Ji oll oYeos 6 Galloe Yl Oe ohne je rill d Sl lal + | je esl la | gy Vaid ee ag . “fs o ‘ —_ ate je ll Aah pla x Vidal Mae gill atl was.\s A ; sre! Jives ae «te 6 2a ey § Eo\u27 % he | we ag ‘ae Jae | slell : Ja " : elal 6 shies. ¢ Sol Ladd | _s su re} vl d . é Bh | Wtaano oa on till & : Ja L pani gs 6 6 dy L. (lea Med dred 59218 pine: ie fi Bt ee : SVEN Gsleu gall : =~ Ja wo glad haces a» gillanbV als al! ~) wh ? cm ALL — Kay a Lol fae 6 \ as | ees G sylja Ga gall JK 4 gull. i Pe halal je galls Slat S| aha (alt all log) etly sobs Je ¢ is?! Ml al ? lca exe Sle y ta gins Jj* # jee as ° jee Po a geet | daeli Va Aa tum § Cle € ssll ‘ JN geet] | am 2 “o scaall oa ib Sine GR) ony sAaPeam 9 udl = Sep ~ Pea id doped SNab ert oral Je ? Ine be sirag rl E Alyn Fs ere ) ot laa Ii hl eal! ene Si Ai, jak | est ‘dks la | pls! Co: 7% Sab! \A | so) 1 al % OPCH ky ? lew SI col hee Vy Gyibl or SI dys dks ol ) ( \AAe cl pte walle, | e a : OE See _ 5 : 7 VAG0 Seely yy — ANNE Se te Vy det— Spd oe Eile s Lik gall : iat 4 pam co Ch bates 98 pares! (Sy ge thy. Sd 4 kim Jad ¢ aLall eb! tyus}i ely eel) WhNs CX Oil b Meal yglen Ot lim L5lol al US Loe yu est SDI Ib be wo Ny ghel Gy pill ee ef SA cen Nie St ata inh gall 43} ll pea) : Sle all s Os Aall, 553 7o3 a)! cnlyaall s J o> deal c} se oval eo Mall, Coville: 8) SMH a. Comal s Teck y Ser og ylaldl daaéacl) 9 out ee Ae) stout s pal Son! gta . gall la cath, . eo lll Se Ns ‘ call \alast 6 xl 6 etl Jat Seal pail Sis Uli Nga fe acl sh aduwal ope iT ue all nla Oh: ony Bled deleall pal 3S, Ly 6 ie gaa blobs Gewi Ot J giall oe Cpa s 6 Cnt robel chad se Lely leg» ys dis gam bf aie Jo! oe Vang hs Na ol Slyke a Bogs ccad it: ADU aay lol als bas ghysl ow oe 6. 5 wth. J e-bel ow! Ce dlls Jad ge Lai pel g ae di ola o) i 93 Chek ata oll alllad Ab gf 5S oles lela ob yl tas osle Ce ol tz ol ll laa ad Uall ko i GB ginal ¢ lal Py ay6 as | 2enall Os w gall 9 Aca ey ol ue lal joa 6 oles esae ol eke 4 aleegi 6 Me a ee s oe ot lull 2 Mn jut Nop c ahd oll * = > + yal! Ic Js eal doh lyst oats nlan!l Jail lie of il gle a ji dé € afi Els evaded ism ¢ chee ws | 55 543) ¢ Linas ald iF atl, lo 9¢ iS Oly ¢ Med, - Rak adn adle G87 Ol ol pad! lls genet i tia La gles Nic del Sa o5e3 4a | 3 Crete! shines. hd Vy asl] “OUI & 2d) Ai Kas arene pee Ol ee! bla ora al ye age cls Y— Jos se — ail oly Him 9 6 tlitlly abl 1 sip Ede es oS. S& J Mam all Ral Ste od ee dal S Ogiyea : ole JI 039 Js 4 J : =u 63325 pedal mil ie CHK) ods oh ey sgl ON ana ¢ Aiall jae beg Jkuals é dab Ol yak ele ley 4‘aga tm 9 Che dadeull 4,8 ¢ OW gly 6 Spore fe Gtall Kus . dla, J! es ‘ é gil ag coke ky Jel get SI ae ord J ae iG til J ghia OW ay2¢ Vs ¢ CagnnallJe & wl] er ev lia 3 Spina ¢ Suill Jit te oss 1s sy. opt ths 6 a5 Ay oy ode at wy 6 obo ce dar pas das! > ue sy ste tLanill -ya *! wibl J éy av | gaSiby : he as ails ¢ « hos sl alull Pi (Sarat, S Jaalls €. sum | of Halal s atl gal gladl ¢ sale suyem gos) des dole ail dno SE CUA, & walls palall, La Slstl a o\laic cB gu cde SM slLL colest call 5 gall Blows pleats 6 OleebY Oleg YK Swill dai § ede SI daly : ob le XI Gin»! az do 5) 4>(L1 1 daai NI eae yb» : a \éall pbs Sgtelll Jay ceed peg c bel yy ILI Js oe Ca 6 Arclvall aca la: é Shs JI stad cde Sich. GA RS SIAN ORT US gc Sh 5 ne ola SG hide § of Kou Sai oly le rly ¢ colle petal QI bss ol « ce vw! nas e Ojo ah Cen lis Lone cud, bs 6 3 par BlasIl ob cya 5 pw SI Gm Le ae ON, Jt bi oS a c Lslacs palif J sl;vA eiimed ¢ S4ml an d law oy ¢ ley len wad 3! ae kell acm FI galSI jet] CP Jalal alice Oy 7 Ol eel jie 15 Sabi! OF Nab. Ale He ayy + dw yA pall “Gi ry Jalal jae dn 3 oa gale wal pws bb - oe ol ee slab Laas | i tom g lay T ML lang Nal cm Web galas Salat ¥ ssleall, facies: (jai dace \- yS, ro Ji! ve 4 Jie Ne lal. Gta leas tea sha ay 3 eds dey) Ket s Mya Vale Cy plat! opal ne 6 dl> tl ode lgjliorl & oly 3 eid lall Pa oy of wera GY, S radia Bley BO gilocs oY Ge bot eee pd vlasii lakes : ole! AS faa 3 c lal oe 353 2 Pyare 5 pd sie luda sl Ol dm cells ye SVL GS clad a ay Gal ol Walk ip dhie goes, W ade ¢ Gad Sli bereVI atid» Mab Sly Lge y satdall Sle glall oye pet > pall J ie la J geal Vaazena eels por deol] sow be SI \ia s (Yo-.uw) Js abac Su} beau! oe | ! gal mls 4 \A\ ge DL (sl ll é Janell fins le lls 2 3 a ‘ els sledll A to Cn Cm dads eo ee els, he Sgebe ee Eos Se GM b pea | er shea) bh” d \pale cna Oe! ile chido cyt lag wre cols 6 pe u lad 2 \c\u27l yes im is i “he ¢ 4 laall coed en eR AWYEY é V gas las & gull wt 6 wiall cat pill Jos. 5 Ob Key! oe art) Fog pel Jano(Sjexo = exo (Saxo alazec _ Jax (S)one(S Jono 6 sd ea 9 52 Sa clage BSG Vy de) ae cual 6 Bam jl: : aay HM esd ds Gl 13 cya Dip dadl s Syall ale \pe cial 5 pa, Stet cal = 5 al Sl asa hs golen Wal c lagi ye laple Oye) dae it, log oléall 95 Soll Sly & gentlyIL Cal — mms phen Re — Je she 6 bdo lb! sas 5 6 SUgll Sal youll shee FF oluill sue jet les ¢dobel os by Jal UG pablil glo c Osh bes ¢ dleSl ose 6 ne aS ode id de 95Je Fb. 9 6 Jel Veit | I cya 2 all S Jalnaos 5 c aS lall chs Aaah gadl Sl cptill o ged colt! la Gijey » GEN es o » jew SI Ayal ¢ ase ‘ | ct late 96 NM ye cede 3T MG! Sue G2 ais Wal Seagal ge Jal Wc ab cle aS o! ‘fale SJ ¢ \y8 cs ee Sg isle) Vag zi! Spel, a » dal Sly sje! ales 3% aaa, 6 pall , heal OR ROSY) Jot wa 9 54.05oe th SI odd az ce one Gono, aoe o* SI syle ® esl pall OW “A on ! Os \ 5 jame J fla HM 3 Ode Ss oh Yes Vle Ogele Casai Ss ive 5A ode \ pall eet S Jone (EROS) ExO SIAN DwoS ol Seely Rad Ol drcbell cols say (ptm Or pee él babs as NOSIS) NOS) Si. ns UG gabe o pei ol tl ah Val PUM 63 cyae vi# y ye Maes io al oe Lats will Call aL. Se. \nd- ‘ ey dys | aS ti » | caevadll ttle Lely ce pt seal aad oly pre SI 4% 4 tle le of Sad c 3h (ill 48 gh MS Ol? Cel Gey Shands ie Ot SLL, ce GB Aa De geal ats ¢ age, GlasVI U2 gall 0 82541 Speweall com Shi ce Ol. Ob gay bbl abs Jy Js whe Vee ell # ald LN allesll y Al Cm by 6 ase cists daw INOS BOCT) MG SOS) MOS) NOS) RO SINS) NO CE) OT) OE) HOSS 4aol all ots ox «. da lall (7 436 pio CoB) Le 9 pale a talale Re wlei ‘gall Cad | gall SULE et Gok SORE EROS NICS) ASN domly Le pants SNe West Ae cenenasd 6 Al ll SLES plaall ye IeKe dP lua Spt Kee SI laa: Ors: 6 oheawal b sel of aed Lanter CHT egg ced ode de By Sus Nis cage y JN shoal) Abbe 4é Yat U2 5c afl! galall ao Sy Slee di salah ut JI a qc oI Gaaelll dm ld ls Gall bail go plas Ge of 4 o » ano) aroS) mo (SH) MoS) OLSON & lai Noy ¢ ald! aledall ode 8 pe : ke gi 9 Minna iy pan chy ide glo: ol dewt, t aKss ae lint cya ot aS y te orl Odd ¢ ablel sl yl pe gt Ula coal Bb bgtll ce ¢ Ak \oa of| oN mst Ol de. Gley! Oyo analstl esta y A dole dads Oly 6 dab dalial yl de yall ga tll 3 2Kalls & Mlezn SI wm: opted! oy le af cl els Pat, peel CS! otal de sl odle Jule «, aalall” ay id Jel wt og! oye 3k! ey ¢ ditt & Jd gl Sie pea rokae dee cedieal 6 26 Nye gi fae wd ails és Se Nobel Ged Jad cis- deKa F gllss « ole so gh | Sle gall Ellen. x lal daaol 4toys. Sehaeow OS Geslall SI AUS te, a, Leng ¢€ 6 Aayts ah c dal ode 893 pall Oe iad lyAle YW Jy OF uN uped cll, Kfar Qt Vgaglaas yl geld « Least’ all ode & pled) Jo ltl ‘ Aube pla! peSs - cr lall ode I ec la! lal éoe ob! gts 3 Vale | gaacel 4 131 | ysde, os si alt pela’ * ed sie ao 9 pyeclet s erste Wel c shy lall ci ie ona, ol 15 ides je db « Ws Igo i ne > 3a eleeill yy Vgetad OF | gaqbatanl oP 3 Ue le pads cde ail JI aaUNT ne ¢ ans AY de els ¢ poe dILI ga Loay Ll ad 95s lee 6S pte Holhl gl a ptlall Sipe dis. Syldll es cll gal tls pial! ab lai a>! ad Lanbl3 lable OK op 6 outasll edo SI este t “9h ¢ cial aaa >i co eluall oF ells whee cb pil le aid Coy ab ance pesmi wolerall culSlog ao Oly 6 MLD ho ab Lleti lie cys PLA oe veal cn 1 a dl |. ot EY! UF all O gid 6 pi 3} oN lai as 7 nT Veal SE GR s GILG & NN oe : oS J gu JI J 96 Gae gill, é cled! ph ab cam dhel s 4c gi) lt Ided OF gd Vo G8 6 Mell webly SLb O59 Se Os.eF She Lok, 6 Sathas,SI soll) Je uae ob oye Spall Ol dha bin! 5 bol 5 ou oeleols 9 ¢ cla dy dla adeys SI the » 38 ie aa yy “6 Ll 5 @. Baalge laeSYI FI Vplaleese on ya tl ob likey WEI ie5 aii 443 lll LA eI deuresll fib eh gull db ase oy ¢ olull iol pos 6 8a 9 ght 3d att L¢l toms I de pai cull aoa Mb ¢ \ple pe Shaisy ¢ SM! BAK ane, ent! 6 édmlgl Olas aaual 4 pall je lall dt\all 6, ages ¢ lacll JI Any, BI at f Vso 5 geal cys exe! ¢ el rs BI jo Ol ebay 4 sy el AS Ul Ogres a lait JT ogee aa Ue & Ide ore: obiI of Ib coh ol sla cs eee Wl Sse Osrde ys LI uv é \aarle aL) 5 45) Atle M3 oS ote! da Hpi ad. fil, « cplizall ol J> J bes al de X21 reeraasares cpliizal fo es. i4,—4 }| « arent eH ll es ole ont « hanll bls 6 PDS og ABI KIS agtal chai Vy Srereeal) Apliall 4 3) Pode S) exe peelpw SALI Ose 5: 1365. (piercing dsm Ob si, . S41! ples spolLl syt5Jl Js wie Ory de KL Spel 0 pw Ayal on O! wlan 4! 5 slid 6 te JI eens} Gh aol Wale de no dls sag’ » Jad Sy ball bs SS ys es oleJey ga SI 1g d5-4 II Pade. Ognamns| of 9 4m15 of oli waa le Lena Ve jm UF gal YN, Ns 6 Agi! ye pple G2 gal YF I csls ol, PU Sols belide Ob cureall yas. Ue lts Va gh Feld SV gentsye lV getty gm ld 1 rene lal § & gamey eenek ANS Osaales ¢ lid al 643 Fg Bll scant Lg Plas O95 LT Le Ot Vs 6 ppmdil de « wl cu ln 98 at y abel él S2 ral b> ode Joly of JI 5 —aull & Joly oss le hd Jd Gl Lage S Crane DISKS ow y \nw Jot Jt ore St Slab 6 be at plonchas ¢ gil wl os aS 3 coed! BAe) Prony Coke! | ged. sat plies \ glantal Nig 6 atintm> SJ SGI aahys jell Gals Sécel Saad sc Wels ol JA! wv \A all tl Vple ogeV Soll Oy Os pall af Ll deb oye = & uaills al d \peusi Curaat Sls ¢ janl 4 21 yadets Saeu al coil gallwf cyaall Blew g20 Steet I3/ O grglatnt Yu piel ena oP fl aeelee on ooh J gall 3 Saal Vai day » Ube. age, d led |Van 9 © PGS ere SAI le ‘S.. Jc olfVt dt AS ld om N cet il cable Als dll gue! ho OFF ley bers Kal g 6 lageras Cad jal Juels ej Ry Nui ars Seal 3 > » oldary oye Gi\ 5 ch od (yee ties cyclen! oom e nd ls 2g cli ? et ll 3 = Gl Val. fal 635 3 w99s flue Sle cob eld of py > Ee Seaall GMI sate Vals 6 CUS lel y F ) cte G file agit Joly Mela py cb «GO ak N; Slam eh Ane 4 ? sawed] poe 4s > re} Ra o* ey 6 henar Sle of \ daa) ss Vel ja SEM Me ngarly lolgh lal ge le Dl diy Co ge leleor les Kaa aley \a liars pall Sgt de GalesV loge ao Ons te ¢ wljaI yl ons (vy) all SF 6 LD. [Goegrai Oghdt Jam spear ely! lat oe pe ils ppiels lela! A deal Lels ond ve b W on JP Wb KI 5 bolle, I 7 Maley lalae Gye OF LANs jl &! es roe cf Ns_pastl Iida.of dm 9 9 al 2 6 Swe Aawhi fone Oasslas wihil © pe dalis ¢ ‘eaaall LSI dag c ale Sb rah ef Seaaee Ky 3 fle! 3 « a 3S dzcle cn Gel gh \das . leat oD pre S| de od! dover Nis sol Ss Jnl oda Sey palbigh el, La » Culd Le decay lel Fel ph HH! Vals ‘ Vener Sub s d lallae aS Fa el de of \- V grad Ih Spat Das 2g dei ie ‘ui co c+ ae CoM Gell ge eae a Sead! ola’ 4 few O85 Kas GEN aren jbl 5 5 Ol: pea lal L as \ sx got lel oy! raat aah © Gg ¢ a y Ld 3il aL \paual vl ; « Piel elas is ee aie onl de (6ot \ass «. Ale wey (? U3 se (or) loom Golvall slgLt ey Pgmls sc sana \Sss aaw (oy ) ilbil — leall Gels la ¢ Gi op aac} es Jl aljls wbdeels as. Gl \¢ Calley AN, oy ee) ae 3M Js este db eobh c . Sols. 6 4 Lae de Cm thd! Geol G cay le arly soy ai ‘ ols | re oS clele atus on a rey | 5 spa sl db Zdual Sylial bh ne \b lanka Le femal 6 Gall le eee ome ae pale | ghoeat 4 pele ole¥I Ol ee! gos ley cdg. Cll d dill, be b paral dl Solel Gl casianid dala ? sash adlaz)l lam S ne Je peal al ~ sil! aS bil N 6595 eX pA Y Sil ys Sit © Nl 6 aly! of oe Gols -ol fam harzeus | fl pee Ses Nig c blall Jat 36 3! inc 4 lal par a> le 3 Jt (uo (ur)’ @ ¢ dowall -ya ot sige dleMN Ol WEN ad Li, Ihc osudl bg 6 dodo pees Jk ee Vad Age Jkt es @. SKS ib wai eee! Yo : dé lay lpacia ¢ sho 8 oKK25 Sl deal alge Jt 1? Cena ah Saath S ae ead Nigel @. gal Oe few Gesly : Els \u27 oh gh ls gm ge, 6 Raelll ode eid ge ail I YB all indell 2s JI wd lanl y Ags deolys Kt exe 9 SI ol dae 5, A lim dar Sed ale «2 Bw 4 pa Jib G Mela oleate yum oe tls i »: db ks ol oe LI 1 GM 6 A gélell dee Qlitne gyaed SV de| OMe 5s od lea) ay a. ory YI al slice lal Ail ge te Lid le pail GSI 5 | Sip US Ob fat ily ¢ GAIL! G oni! 51 eS Fe Lise OIey 6 Ty ae Os 6 peyile bade Shale ae d SE Ng Golan age | Ol fi, wlless azreliea : foie | - Nata, 4s er | YT J 9> L ay : le glands « o\3) oe ee obsls lo Ss ‘sd ob sl lye ma SF stmJl I agedls. or gill», OM Ol lie Ls. eke Jad 93 |e +Galdl_s elles, ee a> Ev « J see! Gud! » on Am 3 dita oF 9. cnlwoSl MY 6 paie oleh Uy lee oy ee) —_— die Koel Lea atreig. 16 als Naan + SS ge te [ob od ide ce, i Ole al be Ogee is stacks Azeuho plesad! Oks elf Ble dl V gatatend 8 with sai o laa Y wits J ese eset i ye t ads walé ltl eSde bh jal css Cnt da Aly & Sule (gles ane | O gmaniiia ote wo tl ork ol 3 kL 3i pol (XI ull as be ude © paee F Gita s ¢ lfSI lai ba.aS ams ya chal s\ oe a A eras et » cmb gl anis ie KL II lol jal l> jal 3] « cot ale yp slicil Glass Aa OW goccel y \paye ™ ba] ders Slslt aiad hej! Gola! Gg el> cacllg co tlle ja olde |e ed oldlL 23° BI ¢ les ti 6 ls oh) tL sly Ogrent Ad dad laa! Shes pall dle, els Lapa Syl» bliss oS gil agi tl t ball + Lea) Vanda gS, es oles Jionis « as Al Shel OM ieye Gull Send! ger ots od: od oOot le J) cere! s sayer ios les esse ool Shall CNS nalls lye Why laigl uh a sdney O! boy Of C3 Vgletis ol ollwl Lect Uli gh 8 ied coe! Js lds... wd ylall oylj5 of byashe gal all ook d saps | yales ge ie bk, gall 5M S (LI s dull ) cr paiall al ea t 3 » dayMl detects ay jl silly ieee el mal sy: Job shal abst ow lel « my (nde! OF paaiall lela sg lantcnd pac s ¢ bl jm oy esall oI \da_s sual» dis. asl peil + yh gal gol ode JA cyan thaiSI tie ir ols A 4 ulb ite odds ail Coy jonckl_ neo Oat ¢ ad sMely ode Sater Hy list 6 Ae fe od Agm 9 com V6 dtmgl oy par 0 gefe 39 Sell Go lees nat bell par eI thi ad Vall dl Bb Sore He MEI ae’ ac ¥ S465 odes Any | yeq90! OM ¢ Goll Law ole| cat st ota Ste Jal s 6 dake! Ol so VI O38 6 jana : Vamts cs amare: ch ol sage Ms 2 oh 3 alg ees Nam olume OS Ngace jase ve Adsl ure \ peal Dae la jsal Ot Ngadiin Ob ts « + jedan’ y uo at od 60 |p est! cee y wie Foe I! lai! Corte tle Why Li uml at lal ae I Lager 985 ye daw! Cpls 6 le peice Gu ad 16). al IS DI age lead ole Shy ll pikes Ol seg geal poe Sl gta cAreralls! 5 Sle Gg Ail! laa s65 Sgletl ita a AYA cle od Cre ode Azeeall slj CUI cx ye ae KALI Uesell cee z hic ol ue Vgeddr oe pe J he owl \pe 6 ol gu ot oo! loa o* Sol 4, leaull - ey 7 lensey » Sgcill oleW aru all doy sb ile 5“a Be ht u
Empagliflozin in Patients with Chronic Kidney Disease
No full textBackground The effects of empagliflozin in patients with chronic kidney disease who are at risk for disease progression are not well understood. The EMPA-KIDNEY trial was designed to assess the effects of treatment with empagliflozin in a broad range of such patients. Methods We enrolled patients with chronic kidney disease who had an estimated glomerular filtration rate (eGFR) of at least 20 but less than 45 ml per minute per 1.73 m(2) of body-surface area, or who had an eGFR of at least 45 but less than 90 ml per minute per 1.73 m(2) with a urinary albumin-to-creatinine ratio (with albumin measured in milligrams and creatinine measured in grams) of at least 200. Patients were randomly assigned to receive empagliflozin (10 mg once daily) or matching placebo. The primary outcome was a composite of progression of kidney disease (defined as end-stage kidney disease, a sustained decrease in eGFR to < 10 ml per minute per 1.73 m(2), a sustained decrease in eGFR of & GE;40% from baseline, or death from renal causes) or death from cardiovascular causes. Results A total of 6609 patients underwent randomization. During a median of 2.0 years of follow-up, progression of kidney disease or death from cardiovascular causes occurred in 432 of 3304 patients (13.1%) in the empagliflozin group and in 558 of 3305 patients (16.9%) in the placebo group (hazard ratio, 0.72; 95% confidence interval [CI], 0.64 to 0.82; P < 0.001). Results were consistent among patients with or without diabetes and across subgroups defined according to eGFR ranges. The rate of hospitalization from any cause was lower in the empagliflozin group than in the placebo group (hazard ratio, 0.86; 95% CI, 0.78 to 0.95; P=0.003), but there were no significant between-group differences with respect to the composite outcome of hospitalization for heart failure or death from cardiovascular causes (which occurred in 4.0% in the empagliflozin group and 4.6% in the placebo group) or death from any cause (in 4.5% and 5.1%, respectively). The rates of serious adverse events were similar in the two groups. Conclusions Among a wide range of patients with chronic kidney disease who were at risk for disease progression, empagliflozin therapy led to a lower risk of progression of kidney disease or death from cardiovascular causes than placebo
Design and baseline characteristics of the finerenone in reducing cardiovascular mortality and morbidity in diabetic kidney disease trial
No full textBackground: Among people with diabetes, those with kidney disease have exceptionally high rates of cardiovascular (CV) morbidity and mortality and progression of their underlying kidney disease. Finerenone is a novel, nonsteroidal, selective mineralocorticoid receptor antagonist that has shown to reduce albuminuria in type 2 diabetes (T2D) patients with chronic kidney disease (CKD) while revealing only a low risk of hyperkalemia. However, the effect of finerenone on CV and renal outcomes has not yet been investigated in long-term trials.
Patients and Methods: The Finerenone in Reducing CV Mortality and Morbidity in Diabetic Kidney Disease (FIGARO-DKD) trial aims to assess the efficacy and safety of finerenone compared to placebo at reducing clinically important CV and renal outcomes in T2D patients with CKD. FIGARO-DKD is a randomized, double-blind, placebo-controlled, parallel-group, event-driven trial running in 47 countries with an expected duration of approximately 6 years. FIGARO-DKD randomized 7,437 patients with an estimated glomerular filtration rate >= 25 mL/min/1.73 m(2) and albuminuria (urinary albumin-to-creatinine ratio >= 30 to <= 5,000 mg/g). The study has at least 90% power to detect a 20% reduction in the risk of the primary outcome (overall two-sided significance level alpha = 0.05), the composite of time to first occurrence of CV death, nonfatal myocardial infarction, nonfatal stroke, or hospitalization for heart failure.
Conclusions: FIGARO-DKD will determine whether an optimally treated cohort of T2D patients with CKD at high risk of CV and renal events will experience cardiorenal benefits with the addition of finerenone to their treatment regimen.
Trial Registration: EudraCT number: 2015-000950-39; ClinicalTrials.gov identifier: NCT02545049
